Sharekhan

Consumer demand may be sluggish, but some FMCG companies are defying the trend! Sharekhan analysts unveil their top picks after Q3FY24 Read now - https://www.livemint.com/market/stock-market-news/consumers-q3-review-britannia-industries-godrej-consumer-tata-consumer-among-top-picks-of-sharekhan-11708333667294.html#StockMarket #FMCG #Investment #Sharekhan #Q3Results #TopPicks #Resilience #GrowthPotential Cred - Live Mint #StockMarket #FMCG #Investment #Sharekhan #Q3Results #TopPicks #Resilience #GrowthPotential

Consumer demand may be sluggish, but some FMCG companies are defying the trend! Sharekhan analysts unveil their top picks after Q3FY24 Read now Live Mint article - https://t.co/e1TWa0TyQL#StockMarket #FMCG #Investment #Sharekhan #Q3Results #TopPicks #Resilience… https://t.co/vluQQIQE0U #StockMarket #FMCG #Investment #Sharekhan #Q3Results #TopPicks #Resilience

#SharekhanResearch retain +ve view on Hi-tech pipes with 15% upside potential, Strong #Q3FY23, Tgt 35%+/20-25% rev… https://t.co/pKLe0Qdaud #SharekhanResearch #Q3FY23

#SharekhanResearch retain Buy on Greenpanel Inds with 12 mnths revised PT of Rs385, In-line #Q3FY23, Mgmt tgt 20%/2… https://t.co/5aR7dGNBMR #SharekhanResearch #Q3FY23

#SharekhanResearch retain Buy on Greenlam Inds with 12 mnths revised PT of Rs385, In-line #Q3FY23, Mgmt tgt 20%/20-… https://t.co/MwqAxgsYJG #SharekhanResearch #Q3FY23

#SharekhanFNA #SharekhanResearch #Q3FY22 Pharma Review- weak qtr, strng gwth in India bizz, US gwth muted while cos… https://t.co/AdYDkj4Qai #SharekhanFNA #SharekhanResearch #Q3FY22

#SharekhanFNA #SharekhanResearch retains Buy rating on #Divis (PT Rs 5620) #Q3FY22 strng qtr, rslts ahead of est; C… https://t.co/svLM1XfNwC #SharekhanFNA #SharekhanResearch #Divis #Q3FY22

#SharekhanResearch retains Positive view on #Metropolis (Upside 35%) #Q3FY22 weak qtr; focus to grow B2C biz & incr… https://t.co/4e8KPiHe03 #SharekhanResearch #Metropolis #Q3FY22

#SharekhanFNA #SharekhanResearch retains Hold on #StridesPharma (PT Rs450) #Q3FY22 was another weak qtr; near term… https://t.co/8nI3HniDms #SharekhanFNA #SharekhanResearch #StridesPharma #Q3FY22